Welcure Drugs and Pharmaceuticals Limited (BOM:524661)
0.3700
-0.0100 (-2.63%)
At close: Jan 20, 2026
BOM:524661 Revenue
Welcure Drugs and Pharmaceuticals had revenue of 656.24M INR in the quarter ending September 30, 2025, with 167.31% growth. This brings the company's revenue in the last twelve months to 3.66B, up 1,389.00% year-over-year. In the fiscal year ending March 31, 2025, Welcure Drugs and Pharmaceuticals had annual revenue of 245.50M.
Revenue (ttm)
3.66B
Revenue Growth
+1,389.00%
P/S Ratio
0.12
Revenue / Employee
n/a
Employees
n/a
Market Cap
432.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 245.50M | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | 1.05M | -283.43K | -21.26% |
| Mar 31, 2021 | 1.33M | 508.43K | 61.63% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Murae Organisor | 8.59B |
| Walpar Nutritions | 757.46M |
| JFL Life Sciences | 744.78M |
| Sandu Pharmaceuticals | 667.62M |
| Shelter Pharma | 598.96M |
| Gujarat Terce Laboratories | 501.95M |
| Panjon | 463.51M |
| Biofil Chemicals and Pharmaceuticals | 455.49M |